Pharmacological modulation of GITRL/GITR system: therapeutic perspectives.
about
Novel Immunotherapeutic Approaches for Head and Neck Squamous Cell CarcinomaMechanisms of action of therapeutic antibodies for cancerExpansion of regulatory GITR+CD25 low/-CD4+ T cells in systemic lupus erythematosus patients.Th17/Treg cells imbalance and GITRL profile in patients with Hashimoto's thyroiditis.Enhanced CD8 T cell responses through GITR-mediated costimulation resolve chronic viral infection.GITR engagement in combination with CTLA-4 blockade completely abrogates immunosuppression mediated by human liver tumor-derived regulatory T cells ex vivo.Correlation of circulating glucocorticoid-induced TNFR-related protein ligand levels with disease activity in patients with systemic lupus erythematosus.Clinical targeting of the TNF and TNFR superfamiliesThe TNF receptor-ligands 4-1BB-4-1BBL and GITR-GITRL in NK cell responses.Importance of reverse signaling of the TNF superfamily in immune regulation.The TNF family in T cell differentiation and function--unanswered questions and future directions.Targeting tumor-necrosis factor receptor pathways for tumor immunotherapyClinical impact of checkpoint inhibitors as novel cancer therapies.Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases.Harnessing co-stimulatory TNF receptors for cancer immunotherapy: Current approaches and future opportunities.Authentic GITR Signaling Fails To Induce Tumor Regression unless Foxp3+ Regulatory T Cells Are Depleted.Characterization of a new regulatory CD4+ T cell subset in primary Sjögren's syndrome.Metabolism-associated danger signal-induced immune response and reverse immune checkpoint-activated CD40+ monocyte differentiation.Low frequency of GITR+ T cells in ex vivo and in vitro expanded Treg cells from type 1 diabetic patients.Enhanced immunotherapy by combining a vaccine with a novel murine GITR ligand fusion protein.Sjögren's syndrome-like autoimmune sialadenitis in MRL-Faslpr mice is associated with expression of glucocorticoid-induced TNF receptor-related protein (GITR) ligand and 4-1BB ligand.Modulation of tumor immunity: a patent evaluation of WO2015026684A1.Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications.Enhanced immune-modulatory effects of thalidomide and dexamethasone co-treatment on T cell subsets.Enhanced in vitro refolding of soluble human glucocorticoid-induced TNF receptor-related ligand.Influenza-Activated ILC1s Contribute to Antiviral Immunity Partially Influenced by Differential GITR Expression.Synergistic antitumor responses by combined GITR activation and sunitinib in metastatic renal cell carcinoma.CD8+ T cells: GITR matters.
P2860
Q28071998-D2CA5D14-1E22-4880-B330-F86F43B7D98BQ28385366-B8B08FD0-2790-4212-A1F1-3836944DAC22Q34401977-A65188F1-67E7-45E1-8972-60755EBA1504Q34833567-9F3A3432-E9BF-4846-897F-182DE0A8815BQ35147454-19F676E3-B105-43A6-89FC-957BE68828D2Q36256549-D7AE212A-FCFB-4D01-9A53-136B6C8E8287Q36464495-26ABBEAB-BE1E-48C7-8F1F-9735E3A30213Q36762882-172C0499-DB93-496F-93ED-7305BE8F1536Q38073762-E21497B6-2903-4FFF-B297-D99D518E622FQ38096027-EDF8FAA3-C26A-49DB-82DB-034FE8C2D9B5Q38194782-B210C2B3-820C-4700-96A1-1A5C5D6A0E29Q38214095-FFBCE7C4-08EB-467C-9FAD-C51CBFCE8D16Q38262593-F4F95511-A769-40F7-B3DE-81F48D276F66Q38748557-3A69EB21-BB65-4C6E-9986-22824F570F5EQ38770814-F920219F-EF97-46C5-B386-0C2D05648056Q38831262-D052C72E-1F1E-4644-AEB7-6D52F5AF820BQ39418862-C548368F-3846-4F06-8236-0F539CC41E61Q39454807-24F973F3-7BA4-491E-9A8B-95F4DE050005Q43956059-A9D9B1E4-C1BB-4E71-A0DD-EEBC5048749FQ44302880-E2A71C0A-FBDE-455D-8705-56D427D4334EQ45975829-749326BF-C750-4ED7-90B5-ABED396E709DQ46640448-C85B3E54-9F9B-4BD3-8E92-E12E93912172Q47325431-7749FD26-3F14-40C6-AE6A-998B0EA01B9CQ48010492-D8343B67-FDE8-4AAB-B15A-D73A3612FA5BQ51047152-10D98A3F-B2AF-4973-9C85-733F1C8AFBEEQ52603630-8BDF02AD-3B9E-4D07-93D7-12A9A86B923AQ53179258-A5924236-F857-4F2A-BAFF-D64EEB1D072EQ55450551-E8768295-9AB2-4B25-B183-179DAE7512B4
P2860
Pharmacological modulation of GITRL/GITR system: therapeutic perspectives.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Pharmacological modulation of GITRL/GITR system: therapeutic perspectives.
@ast
Pharmacological modulation of GITRL/GITR system: therapeutic perspectives.
@en
type
label
Pharmacological modulation of GITRL/GITR system: therapeutic perspectives.
@ast
Pharmacological modulation of GITRL/GITR system: therapeutic perspectives.
@en
prefLabel
Pharmacological modulation of GITRL/GITR system: therapeutic perspectives.
@ast
Pharmacological modulation of GITRL/GITR system: therapeutic perspectives.
@en
P2093
P2860
P50
P1476
Pharmacological modulation of GITRL/GITR system: therapeutic perspectives
@en
P2093
Carlo Riccardi
Giuseppe Nocentini
Maria Grazia Petrillo
Simona Ronchetti
P2860
P304
P356
10.1111/J.1476-5381.2011.01753.X
P407
P577
2012-04-01T00:00:00Z